my account  log out
 

CTLA4[Biotinylated]:B7-2 Inhibitor Screening Assay Kit

Create: 12/17/2018
Expired Date:never
Category: Diagnostic equipment [Health&Medical&Pharmaceutical]
Message:B7-2 (CD86) signaling through CTLA4(CD152) has been shown to inhibit T cell activation. This co-inhibitory pathway can be overactive in many tumors, enabling cancers to escape the host"s immune system. CTLA4-blocking antibodies, including Ipilimumab (Yervoy) and Tremelimumab, have shown clinical efficacy in treating cancer. https://www.creativebiomart.net/ctla4biotinylatedb7-2-inhibitor-screening-assay-kit-465598.htm
City:[US] 
Location:
 
Aug 25 2019Recombinant Human FGF2, None tagged434
Aug 25 2019Recombinant Human PVRL2, None tagged449
Aug 25 2019Recombinant Human PF4, None tagged460
Aug 25 2019Recombinant Human CXADR, Fc-His tagged484
Aug 25 2019Recombinant Mouse Cxadr, Fc-His tagged485
Aug 25 2019Recombinant Human CX3CL1, His tagged480
Aug 25 2019Recombinant Human CST5, His tagged437
Aug 25 2019Recombinant Human CPE, Fc tagged442
Aug 25 2019Recombinant Human Met, Fc-His tagged459
Aug 25 2019Recombinant Human CEACAM1, His tagged454

return back

Copyright © toextrade Inc. All rights reserved. Contact us